Intergroup Trial of Adjuvant Chemotherapy in Adenocarcinoma of the Stomach (ITACA-S) trial: Comparison of a sequential treatment with irinotecan (CPT-11) plus 5-fluorouracil (5-FU)/folinic acid (LV) followed by docetaxel and cisplatin versus a 5-FU/LV regimen as postoperative treatment for radically resected gastric cancer.Emilio Bajetta, Lorenza Landi, Armando Santoro et al.|Journal of Clinical Oncology|2012Cited by 15
Intergroup Trial of Adjuvant Chemotherapy in Adenocarcinoma of the Stomach (ITACA-S) trial: Comparison of a sequential treatment with irinotecan (CPT-11) plus 5-fluorouracil (5-FU)/folinic acid (LV) followed by docetaxel and cisplatin versus a 5-FU/LV regimen as postoperative treatment for radically resected gastric cancer.Emilio Bajetta, Irene Floriani, Maria Di Bartolomeo et al.|Journal of Clinical Oncology|2012Cited by 8
Survival analysis of a multicentre, randomized phase 3 study on the optimization of the combination of bevacizumab with FOLFOX/OXXEL in patients with metastatic colorectal cancer (mCRC)Antonio Avallone, Maria Carmela Piccirillo, Guglielmo Nasti et al.|Annals of Oncology|2018Cited by 0